Clinical Trial Detail

NCT ID NCT02117024
Title A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Heat Biologics
Indications

lung non-small cell carcinoma

Therapies

Cyclophosphamide + HS-110

Pemetrexed Disodium

Vinorelbine

Erlotinib

Gemcitabine

Docetaxel

Paclitaxel

Age Groups: adult

No variant requirements are available.